Genelux GNLX
NASDAQ GNLX
$2.72 -0.02 (-0.73%)
At close: Aug 21, 2026 · 4:00 PM EDT

Genelux (GNLX) Cash from Investing Activities (2022 - 2026)

Genelux (GNLX) posted quarterly Cash from Investing Activities of -$8.5 million for Q1 2026, down 343.35% year-over-year from $3.5 million in Q1 2025, and down 230.09% quarter-over-quarter from $6.6 million in Q4 2025.

Genelux (GNLX) Cash from Investing Activities (2022 - 2026) Analysis & Trends

Genelux's Cash from Investing Activities history runs 5 years deep, the most recent figure standing at -$8.5 million for Q1 2026.

  • In Q1 2026, Cash from Investing Activities fell 343.35% year-over-year to -$8.5 million; the TTM figure through Mar 2026 stood at $93000.0 (up 103.17% YoY), while the FY2025 annual figure was $12.1 million, up 249.32% from the prior year.
  • Cash from Investing Activities for Q1 2026 stood at -$8.5 million, down from $6.6 million in the prior quarter.
  • The five-year high for Cash from Investing Activities was $6.7 million in Q4 2024, with the low at -$17.1 million in Q2 2024.
  • The 5-year median for Cash from Investing Activities is -$193000.0 (2023), against an average of -$1.4 million.
  • Peak annual rise in Cash from Investing Activities reached 1541.16% in 2024, while the deepest fall reached 4219.7% in 2024.
  • Genelux's Cash from Investing Activities stood at -$15000.0 in 2022, then sank by 92846.67% to -$13.9 million in 2023, then jumped by 147.87% to $6.7 million in 2024, then decreased by 1.65% to $6.6 million in 2025, then plunged by 230.09% to -$8.5 million in 2026.
  • Business Quant data shows GNLX's Cash from Investing Activities at -$8.5 million in Q1 2026, $6.6 million in Q4 2025, and $4.7 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn -45.80 Mn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn -92.70 Mn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 329.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn -49.35 Mn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn -363.46 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -3.17 Bn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 24.51 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - -229.72 Mn
10 Genelux 119.87 Mn 119.87 Mn - -8.54 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -8.54 Mn
Mar 31, 2026 -8.54 Mn
Dec 31, 2025 6.56 Mn
Dec 31, 2025 6.56 Mn
Sep 30, 2025 4.72 Mn
Sep 30, 2025 4.72 Mn
Jun 30, 2025 -2.65 Mn
Jun 30, 2025 -2.65 Mn
Mar 31, 2025 3.51 Mn
Mar 31, 2025 3.51 Mn
Dec 31, 2024 6.67 Mn
Dec 31, 2024 6.67 Mn
Sep 30, 2024 3.99 Mn
Sep 30, 2024 3.99 Mn
Jun 30, 2024 -17.11 Mn
Jun 30, 2024 -17.11 Mn
Mar 31, 2024 -1.69 Mn
Mar 31, 2024 -1.69 Mn
Dec 31, 2023 -13.94 Mn
Dec 31, 2023 -13.94 Mn